Fundamental Analysis.
1. Industry: Corona Vaccin ++
2. Price: Relatively Cheap
3. Upward potential: 20-40%
4. Risk-Reward Ratio: 1:10
Technical Analysis.
1. Volume is growing
2. Support of the MA30
4. Financial Morningstar Score: A
4. Growth rate: 93%
5. Short-term target: 180
6. Long term target: 200-
7. High Dividend Rate
1. Industry: Corona Vaccin ++
2. Price: Relatively Cheap
3. Upward potential: 20-40%
4. Risk-Reward Ratio: 1:10
Technical Analysis.
1. Volume is growing
2. Support of the MA30
4. Financial Morningstar Score: A
4. Growth rate: 93%
5. Short-term target: 180
6. Long term target: 200-
7. High Dividend Rate
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.